Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer.
暂无分享,去创建一个
[1] P. Bouchard,et al. Mycobacterium ulcerans infections cause progressive muscle atrophy and dysfunction, and mycolactone impairs satellite cell proliferation. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.
[2] G. Pluschke,et al. The genome, evolution and diversity of Mycobacterium ulcerans. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[3] B. Foxwell,et al. The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function. , 1999, Journal of immunology.
[4] S. Cole,et al. Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans , 2009, Nature Reviews Microbiology.
[5] E. Walker,et al. Ecology and Transmission of Buruli Ulcer Disease: A Systematic Review , 2010, PLoS neglected tropical diseases.
[6] Y. Kishi,et al. Total synthesis of the mycolactones. , 2002, Organic letters.
[7] Pierre Legras,et al. Impact of Mycobacterium ulcerans Biofilm on Transmissibility to Ecological Niches and Buruli Ulcer Pathogenesis , 2007, PLoS pathogens.
[8] Enrico Colombo,et al. A Mycobacterium ulcerans toxin, mycolactone, induces apoptosis in primary human keratinocytes and in HaCaT cells. , 2010, Microbes and infection.
[9] B. Marston,et al. Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer disease. , 2000, Emerging infectious diseases.
[10] Y. Kazumi,et al. Synthesis and structure of two new mycolactones isolated from M. ulcerans subsp. shinshuense. , 2012, Organic Letters.
[11] Marion Leclerc,et al. Mycolactone Diffuses from Mycobacterium ulcerans–Infected Tissues and Targets Mononuclear Cells in Peripheral Blood and Lymphoid Organs , 2008, PLoS neglected tropical diseases.
[12] P. Small,et al. Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans. , 1998, Infection and immunity.
[13] S. Rose-John,et al. The importance of shedding of membrane proteins for cytokine biology. , 2000, European cytokine network.
[14] J. Grosset,et al. Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife? , 2011, Future microbiology.
[15] Sarojini Adusumilli,et al. Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[16] G. Pluschke,et al. Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer). , 2009, Expert opinion on biological therapy.
[17] Sarojini Adusumilli,et al. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo , 2005, Cellular microbiology.
[18] Sarojini Adusumilli,et al. Mycolactone-Mediated Inhibition of Tumor Necrosis Factor Production by Macrophages Infected with Mycobacterium ulcerans Has Implications for the Control of Infection , 2007, Infection and Immunity.
[19] B. Foxwell,et al. Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism1 , 2009, The Journal of Immunology.
[20] Yoshito Kishi,et al. Chemistry of mycolactones, the causative toxins of Buruli ulcer , 2011, Proceedings of the National Academy of Sciences.
[21] J. Guarner,et al. Histopathologic Features of Mycobacterium ulcerans Infection , 2003, Emerging infectious diseases.
[22] Emmanuelle Perret,et al. Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin , 2005, Cellular microbiology.
[23] Hui Hong,et al. A Novel Mycolactone from a Clinical Isolate of Mycobacterium ulcerans Provides Evidence for Additional Toxin Heterogeneity as a Result of Specific Changes in the Modular Polyketide Synthase , 2005, Chembiochem : a European journal of chemical biology.
[24] Angelo Martino,et al. Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone , 2007, The Journal of experimental medicine.
[25] C. Demangel,et al. A diverted total synthesis of mycolactone analogues: an insight into Buruli ulcer toxins. , 2011, Chemistry.
[26] T. Grammer,et al. A Newly Discovered Mycobacterial Pathogen Isolated from Laboratory Colonies of Xenopus Species with Lethal Infections Produces a Novel Form of Mycolactone, the Mycobacterium ulcerans Macrolide Toxin , 2005, Infection and Immunity.
[27] W. Hockmeyer,et al. Further characterization of Mycobacterium ulcerans toxin , 1978, Infection and immunity.
[28] Pascal Lenormand,et al. Mycolactone Diffuses into the Peripheral Blood of Buruli Ulcer Patients - Implications for Diagnosis and Disease Monitoring , 2011, PLoS neglected tropical diseases.
[29] P. Anderson. Post-transcriptional control of cytokine production , 2008, Nature Immunology.
[30] M. Goto,et al. Mycolactone Is Responsible for the Painlessness of Mycobacterium ulcerans Infection (Buruli Ulcer) in a Murine Study , 2008, Infection and Immunity.
[31] A. Filho,et al. Infection with Mycobacterium ulcerans Induces Persistent Inflammatory Responses in Mice , 2005, Infection and Immunity.
[32] Jun Li,et al. Structure-Activity Relationship Studies on the Macrolide Exotoxin Mycolactone of Mycobacterium ulcerans , 2013, PLoS neglected tropical diseases.
[33] S. Barik,et al. Translation Control: A Multifaceted Regulator of Inflammatory Response , 2010, The Journal of Immunology.
[34] C. Robinson,et al. Microbiological, Histological, Immunological, and Toxin Response to Antibiotic Treatment in the Mouse Model of Mycobacterium ulcerans Disease , 2013, PLoS neglected tropical diseases.
[35] A. Kemp,et al. Acquired T-helper 1 lymphocyte anergy following infection with Mycobacterium ulcerans. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] J. Pedrosa,et al. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer. , 2009, The Lancet. Infectious diseases.
[37] R. Donnell,et al. Mycobacterium ulcerans causes minimal pathogenesis and colonization in medaka (Oryzias latipes): an experimental fish model of disease transmission. , 2012, Microbes and infection.
[38] K. Dobos,et al. Mycobacterium ulcerans Cytotoxicity in an Adipose Cell Model , 2001, Infection and Immunity.
[39] Georges Bismuth,et al. Mycolactone Suppresses T Cell Responsiveness by Altering Both Early Signaling and Posttranslational Events , 2009, The Journal of Immunology.
[40] F. Portaels,et al. Heterogeneity of Mycolactones Produced by Clinical Isolates of Mycobacterium ulcerans: Implications for Virulence , 2003, Infection and Immunity.
[41] J. Pedrosa,et al. Evidence for an Intramacrophage Growth Phase of Mycobacterium ulcerans , 2006, Infection and Immunity.
[42] W. Meyers,et al. Immunosuppressive properties of the soluble toxin from Mycobacterium ulcerans. , 1988, The Journal of infectious diseases.
[43] F. Portaels,et al. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection. , 2011, Dermatologic clinics.
[44] Vasudevan Seshadri,et al. Translational control by the 3'-UTR: the ends specify the means. , 2003, Trends in biochemical sciences.
[45] P. Small,et al. Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans. , 2003, Microbial pathogenesis.
[46] Marie-France Carlier,et al. Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation. , 2013, The Journal of clinical investigation.
[47] P. Small,et al. A Mycobacterium ulcerans Toxin, Mycolactone, Causes Apoptosis in Guinea Pig Ulcers and Tissue Culture Cells , 2000, Infection and Immunity.
[48] Hui Hong,et al. Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer , 2009, PLoS neglected tropical diseases.
[49] J. Saklatvala,et al. Regulation of tumour necrosis factor α mRNA stability by the mitogen‐activated protein kinase p38 signalling cascade , 2000, FEBS letters.
[50] Matthew L Albert,et al. Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease. , 2009, The Journal of infectious diseases.
[51] D. Connor,et al. Mycobacterium ulcerans infection (with comments on pathogenesis). , 1965, International journal of Leprosy.
[52] D. Chatterjee,et al. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. , 1999, Science.
[53] K. Fitzgerald,et al. Regulation of inflammasome signaling , 2012, Nature Immunology.
[54] Georges Bismuth,et al. Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression , 2011, Proceedings of the National Academy of Sciences.